Get an iPhone 14 Pro on us with select trade-in and qualifying Unlimited plan
Get the new iPhone 14 on the One Unlimited for iPhone plan from Verizon, the…
News
HG Semiconductor Enters into Strategic Cooperation Framework Agreement with the Family Trust of GCL Technology Founder Mr. Zhu Gongshan
HONG KONG, Sep 8, 2022 – (ACN Newswire) – HG Semiconductor Limited (“HG Semiconductor”, together…
HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of Fruquintinib in Refractory Metastatic Colorectal Cancer from the Upcoming ESMO 2022 Presentation
— Fruquintinib treatment reduced the risk of death by 34% in metastatic colorectal cancer (0.66…
CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051
– Presentation at World ADC Conference in San Diego – – CX-2051 integrates CytomX core…
Elevar Therapeutics Announces Camrelizumab Plus Rivoceranib Significantly Prolonged Overall Survival and Progression-Free Survival Versus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma During Phase 3 Trial, a Joint Program With Hengrui Pharma
Top-line findings will be presented Sept. 10 at the annual European Society for Medical Oncology…
TheCapitalNet awarded Best Private Market FinTech Solutions Provider 2022 by Wealth & Finance International
MENLO PARK, CA & HYDERBAD, IN, Sep 8, 2022 – (ACN Newswire) – TheCapitalNet, Inc.,…
HCA Healthcare, Inc. to Present at Leveraged Finance Conference
NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare…
The New England Journal of Medicine Publishes Second Manuscript Reporting Positive Phase 2 Results for Biogen’s Litifilimab (BIIB059) in Lupus
Part A results from the two-part Phase 2 LILAC study show litifilimab significantly reduced disease…
Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster…
Oncternal Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Agra Ventures Appoints Nick Kuzyk as Interim Chief Executive Officer
David Grand has Resigned as CEO and Chairman of the Company Effective Immediately to Pursue…
Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.
Leverages Arcutis’ deep dermatology expertise and broad biologics experience to accelerate Ducentis’ lead compound, DS-234,…
22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer
BUFFALO, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
Surface Oncology to Participate in the Baird 2022 Global Healthcare Conference
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7 Years
Montrouge, France, September 7, 2022 DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using…
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract…
Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Erasca Presents Promising Preliminary Phase 1/1b Monotherapy Data for ERAS-007 ERK and ERAS-601 SHP2 Inhibitors Supporting Ongoing and Future Combination Trials
23% (6/26) of patients with RAS/MAPK-altered non-CRC solid tumors and 44% (4/9) with BRAF-driven non-CRC…
Terns Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
FOSTER CITY, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Logiq Enters the Roofing Market, Further Expands its Presence in the Home Improvement Vertical
NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a provider of digital…